查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1683380

全球智慧支架市場 - 2025 至 2033 年

Global Smart Stents Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球智慧支架市場規模達 23 億美元，預計到 2033 年將達到 40.1 億美元，2025-2033 年預測期內的複合年成長率為 5.7%。

智慧支架是一種先進的醫療設備，用於治療身體血管或其他管狀結構的阻塞或狹窄。與僅提供結構支撐以保持血管暢通的傳統支架不同，智慧支架配備了整合感測器和技術，可實現即時監控和增強功能。這些感測器可以追蹤各種生理參數，如血流、壓力、溫度或組織氧水平，在手術期間和手術後為醫療專業人員提供寶貴的資料。

市場動態：

促進因素與約束因素

微創手術需求不斷成長

對微創手術的需求不斷成長，預計將推動智慧支架市場的發展，使這些先進的設備更受醫療保健提供者和患者的青睞。微創手術有切口小、恢復時間短、術後疼痛少等優點，正成為治療心血管疾病、腎臟疾病和其他血管疾病的首選方法。例如，根據克利夫蘭診所的研究，美國的醫療保健提供者每年執行約 60 萬例冠狀動脈支架手術。

智慧支架整合了感測器，可用於即時監測、藥物傳輸和提高手術精度，與微創治療日益成長的趨勢完美契合。這些支架使外科醫生能夠監測動脈或血管的狀況，降低併發症的風險，改善患者的治療效果，同時最大限度地減少更大、更具侵入性的手術的需要。隨著對最大限度減少創傷和恢復時間的手術的需求不斷成長，智慧支架將在推動市場發展方面發揮關鍵作用。

智慧支架成本高昂

智慧感測器的高成本預計將限制其普及性，從而阻礙智慧支架市場的發展。智慧支架採用了先進的感測器技術，可以實現即時監測和資料傳輸，但這些感測器的開發和製造成本很高。增加的生產成本通常會轉嫁給醫療保健提供者和患者，從而使智慧支架的價格明顯高於傳統支架。這可能會導致採用率下降，特別是在醫療保健預算有限的發展中國家。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 微創手術需求不斷成長
      • 慢性病發生率上升
    • 限制
      • 智慧感測器成本高昂
      • 監管挑戰
    • 機會
      • 不斷進步的技術
    • 影響分析

第5章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的既定領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 6 章：按類型

  • 心血管智慧支架
  • 泌尿科智慧支架
  • 膽道智慧支架
  • 呼吸智慧支架
  • 其他

第 7 章：按最終用戶

  • 醫院
  • 門診手術中心 (ASC)
  • 專科診所

第 8 章：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第9章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第10章：公司簡介

  • Cordis
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 主要進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Boston Scientific Corporation
  • Abbott
  • Medtronic
  • Balton
  • Biotronik

第 11 章：附錄

簡介目錄
Product Code: MD9320

The global smart stents market reached US$ 2.3 billion in 2024 and is expected to reach US$ 4.01 billion by 2033, growing at a CAGR of 5.7% during the forecast period 2025-2033.

Smart stents are advanced medical devices designed to treat blockages or narrowing in blood vessels or other tubular structures in the body. Unlike traditional stents, which simply provide structural support to keep blood vessels open, smart stents are equipped with integrated sensors and technology that enable real-time monitoring and enhanced functionality. These sensors can track various physiological parameters such as blood flow, pressure, temperature, or tissue oxygen levels, providing valuable data to healthcare professionals during and after procedures.

Market Dynamics: Drivers & Restraints

Increasing Demand for Minimally Invasive Procedures

The increasing demand for minimally invasive procedures is expected to drive the smart stents market by making these advanced devices more desirable for both healthcare providers and patients. Minimally invasive procedures, which offer benefits such as smaller incisions, reduced recovery times, and less post-operative pain, are becoming the preferred option for treating conditions like cardiovascular disease, kidney disorders, and other vascular issues. For instance, according to the Cleveland Clinic study, each year, healthcare providers in the United States perform about 600,000 coronary stent procedures.

Smart stents, which integrate sensors for real-time monitoring, drug delivery, and enhanced precision during surgery, align perfectly with the growing trend toward minimally invasive treatments. These stents enable surgeons to monitor the condition of the artery or vessel, reduce the risk of complications, and improve patient outcomes, all while minimizing the need for larger, more invasive surgeries. As the demand for procedures that minimize trauma and recovery time continues to grow, smart stents are positioned to play a key role in driving the market.

High Costs of Smart Stents

The high costs of smart sensors are expected to hinder the smart stents market by limiting their accessibility. Smart stents incorporate advanced sensor technologies that enable real-time monitoring and data transmission, but these sensors are expensive to develop and manufacture. The increased production costs are often passed on to healthcare providers and patients, making smart stents significantly more expensive than traditional stents. This can lead to a slower adoption rate, particularly in developing countries where healthcare budgets are limited.

Segment Analysis

The global smart stents market is segmented based on the type, end-user and region.

Cardiovascular smart stents in the type segment is expected to dominate the smart stents market

Cardiovascular smart stents are expected to dominate the smart stents market due to the high prevalence of cardiovascular diseases (CVDs) and the increasing adoption of minimally invasive procedures. Cardiovascular diseases, including coronary artery disease and heart attacks, are among the leading causes of death globally, creating a substantial need for effective treatment options. Smart stents in this segment offer enhanced benefits such as real-time monitoring of blood flow, pressure, and vessel conditions, as well as drug delivery systems that can reduce the risk of restenosis (re-narrowing of the arteries). These advanced features provide more precise treatment, better patient outcomes, and faster recovery times, making them highly sought after in the cardiovascular space.

Additionally, with significant advancements in technology and increasing demand for minimally invasive surgeries, cardiovascular smart stents offer a compelling solution for both patients and healthcare providers. For instance, in May 2024, Abbott launched the XIENCE Sierra Everolimus Eluting Coronary Stent System in India, further solidifying its dominance in the cardiovascular smart stents segment. As part of the renowned XIENCE family, the XIENCE Sierra is one of the latest-generation stents designed to treat patients with blocked coronary arteries. This advanced stent system offers unparalleled safety and precision, making it especially effective for the most complex cases encountered by interventional cardiologists. The launch of this next-generation smart stent underscores the continued growth and innovation within the cardiovascular sector.

This combination of high demand for effective cardiovascular treatments and the benefits of advanced smart stent technologies is driving their dominance in the market.

Geographical Analysis

North America is expected to dominate the smart stents market

North America is expected to dominate the smart stents market due to high demand for minimally invasive procedures, and great ability in medical device innovation. The region's healthcare system is quick to adopt cutting-edge technologies, including smart stents, which align with the growing trend toward less invasive surgeries that offer faster recovery and better outcomes.

Leading market players in the region are driving innovation and development in this market. Additionally, North America's region gaining strong regulatory approvals, strong research and development investments and aging population with increasing chronic diseases create a significant demand for smart stents. For instance, in March 2022, Cordis received approval for the S.M.A.R.T. RADIANZ Vascular Stent System by the U.S. Food and Drug Administration (FDA). This self-expanding stent is specifically engineered for radial peripheral procedures, allowing for precise and efficient placement in the iliac and superficial femoral arteries (SFA). The approval of this innovative stent system enhances the existing RADIANZ(TM) Radial Peripheral System, which also includes the BRITE TIP RADIANZ(TM) Guiding Sheath and SABERX RADIANZ PTA Catheter. This comprehensive system is designed to optimize radial access, improve procedural outcomes, and provide high levels of patient satisfaction.

The launch of such cutting-edge technologies further strengthens the growing role of smart stents in minimally invasive treatments, marking a major step forward in the smart stents market. These factors are expected to combinedly drive the region's growth.

Competitive Landscape

The global market players in the smart stents market are Cordis, Boston Scientific Corporation, Abbott, Medtronic, Balton, and Biotronik., among others.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global smart stents market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by End-User
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Demand for Minimally Invasive Procedures
      • 4.1.1.2. Rising Incidence of Chronic Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. High Costs of Smart Sensors
      • 4.1.2.2. Regulatory Challenges
    • 4.1.3. Opportunities
      • 4.1.3.1. Rising Technological Advancements
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest-selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Forces Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Cardiovascular Smart Stents*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Urological Smart Stents
  • 6.4. Biliary Smart Stents
  • 6.5. Respiratory Smart Stents
  • 6.6. Others

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ambulatory Surgical Centers (ASCs)
  • 7.4. Specialty Clinics

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. U.S.
      • 8.2.5.2. Canada
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Germany
      • 8.3.5.2. U.K.
      • 8.3.5.3. France
      • 8.3.5.4. Spain
      • 8.3.5.5. Italy
      • 8.3.5.6. Rest of Europe
  • 8.4. Latin America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Mexico
      • 8.4.5.2. Brazil
      • 8.4.5.3. Argentina
      • 8.4.5.4. Rest of South America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. China
      • 8.5.5.2. India
      • 8.5.5.3. Japan
      • 8.5.5.4. South Korea
      • 8.5.5.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

  • 10.1. Cordis*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Boston Scientific Corporation
  • 10.3. Abbott
  • 10.4. Medtronic
  • 10.5. Balton
  • 10.6. Biotronik

LIST NOT EXHAUSTIVE

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us